Pretreatment edoscopy - Pro & contra: Endoscopy is needed before treatment in all patients with gastroesophageal reflux disease

Endoscopy

Volumn 38, Issue 3, 2006, Pages 271-275

  Pace, F ^a   Manes, G ^a   Conio, M ^b   Bianchi Porro, G ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Sanremo Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; OMEPRAZOLE; PROTON PUMP INHIBITOR;

BARRETT ESOPHAGUS; CANCER EPIDEMIOLOGY; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ESOPHAGOSCOPY; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HEALTH CARE FINANCING; HEALTH PROGRAM; HUMAN; MEDICAL LITERATURE; MEDICAL SPECIALIST; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; REFLUX ESOPHAGITIS; REVIEW; SCREENING TEST; SYMPTOMATOLOGY; ARTICLE;

BARRETT ESOPHAGUS; ESOPHAGOSCOPY; GASTROESOPHAGEAL REFLUX; HUMANS; QUALITY OF LIFE;

EID: 33645049052     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-924971     Document Type: Review

References (46)

1. Pace F, Porro GB. Gastroesophageal reflux disease: a typical spectrum disease (a new conceptual framework is not needed). Am J Gastroenterol 2004; 99: 946-949
2. Pace F, Santalucia F, Bianchi Porro G. Natural history of gastro-oesophageal reflux disease without oesophagitis. Gut 1991; 32: 845-848
3. Pace F, Bollani S, Molteni P et al. Natural history of gastro-oesophageal disease without oesophagitis (NERD): a reappraisal 10 years on. Dig Liver Dis 2004; 36: 111-115
4. Pace F, Bollani S, Manzionna G, Porro GB. Audit of reflux oesophagitis at 4 years. Ital J Gastroenterol Hepatol 1998; 30: 355-360
5. Klauser AG, Schindlbeck NE, Müller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet 1990; 335: 205-208
6. Dent J, Brun J, Fendrick AM et al. An evidence-based appraisal of reflux-disease management. The Genval Workshop Report. Gut 1999; 44 (Suppl 2): S1-S16
7. DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease, Am J Gastroenterol 1999; 94: 1434-1442
8. Fennerty MB, Castell D, Fendrick AM et al. The diagnosis and treatment of GERD in a managed care environment: suggested disease management guidelines. Arch Intern Med 1996; 156: 477-484
9. Baldi F, Crotta S, Penagini R. Guidelines for the diagnostic and therapeutic management of patients with gastro-oesophageal reflux disease: a position statement of the Italian Association of Hospital Gastroenterologists (AIGO), Italian Society of Gastrointestinal Endoscopy (SIED), and Italian Society of Gastroenterology (SIGE). Ital J Gastroenterol Hepatol 1998; 30: 107-112
10. Tytgat GN, Heading RC, Mueller-Lissner S et al. Contemporary understanding and management of reflux and constipation in the general population and pregnancy: a consensus meeting. Aliment Pharmacol Ther 2003; 18: 291-301
11. DeVault KR, Castell DO. Current diagnosis and treatment of gastroesophageal reflux disease. Mayo Clin Proc 1994; 69: 867-876
12. Rai A, Orlando R Gastroesophageal reflux disease. Curr Opin Gastroenterol 1998; 14: 326-333
13. Johnson DA, Fennerty MB. Heartburn severity underestimates erosive esophagitis severity in elderly patients with gastroesophageal reflux disease. Gastroenterology 2004; 126: 660-664
14. Sampliner RE. Updated guidelines for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol 2002; 97: 1888-1895
15. Eloubeidi MA, Provenzale D. Clinical and demographic predictors of Barrett's esophagus among patients with gastroesophageal reflux disease: a multivariate analysis in veterans. J Clin Gastroenterol 2001; 33: 306-309
16. Shaheen NJ, Provenzale D, Sandler RS. Upper endoscopy as a screening and surveillance tool in esophageal adenocarcinoma: a review of the evidence. Am J Gastroenterol 2002; 97: 1319-1327
17. Cooper GS, Yuan Z, Chak A, Rimm AA. Association of prediagnosis endoscopy with stage and survival in adenocarcinoma of the esophagus and gastric cardia. Cancer 2002; 95: 32-38
18. Kearney DJ, Crump C, Maynard C, Bokyo EJ. A case-control study of endoscopy and mortality from adenocarcinoma of the esophagus and gastric cardia in persons with GERD. Gastrointest Endosc 2003; 57: 823-829
19. Corley DA, Levin TR, Habel L et al. Association between surveillance and survival in Barrett's adenocarcinoma: a population-based study. Gastroenterology 2002; 122: 633-640
20. Falk GW. Barrett's esophagus. Gastroenterology 2002; 122: 1569-1591
21. Mokhashi MS, Wildi SM, Glenn TF et al. A prospective, blinded study of diagnostic esophagoscopy with a superthin, stand-alone, battery-powered esophagoscope. Am J Gastroenterol 2003; 98: 2383-2389
22. Nietert PJ, Silverstein MD, Mokhashi MS et al. Cost-effectiveness of screening a population with chronic gastroesophageal reflux. Gastrointest Endosc 2003; 57: 311-318
23. Fennerty MB. Extraesophageal gastroesophageal reflux disease: presentations and approach to treatment. Gastroenterol Clin North Am 1999; 28: 861-874
24. Malagelada JR. Supra-oesophageal manifestations of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2004; 19 (Suppl 1): 43-48
25. Moraes-Filho JP, Cecconello I, Gama-Rodrigues et al. Brazilian consensus on gastroesophageal reflux disease: proposals for assessment, classification, and management. Am J Gastroenterol 2002; 97: 241-248
26. Dent J. The role of the specialist in the diagnosis and short and long term care of patients with gastroesophageal reflux disease. Am J Gastroenterol 2001; 96 (8 Suppl): S22-S26
27. Lundell LR, Dent J, Bennett JR et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999; 45: 172-180
28. Wallace MB, Durkalski VL, Vaugna J et al. Age and alarm symptoms do not predict endoscopic findings in patients with dyspepsia: a multi-center database study. Gut 2001; 49: 29-34
29. Numans ME, van der Graaf Y, de Wit NJ, de Melker RA. How useful is selection based on alarm symptoms in requesting gastroscopy? An evaluation of diagnostic determinants for gastro-oesophageal malignancy. Scand J Gastroenterol 2001; 36: 437-443
30. Blufstein PK, Beck PL, Meddings JB et al. The utility of endoscopy in the management of patients with gastroesophageal reflux symptoms. Am J Gastroenterol 1998; 93: 2508-2512
31. Ellis KK, Oehlke M, Helfand M, Liberman D. Management of symptoms of gastroesophageal reflux disease: does endoscopy influence medical management? Am J Gastroenterol 1997; 92: 1472-1474
32. Turner G, Tham TCK. Does endoscopy alter management for uncomplicated gastroesophageal reflux disease? Gastrointest Endosc 2004; 59: 246
33. Numans ME, Lau J, de Wit NJ, Bonis PA. Short-term treatment with proton pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics. Ann Intern Med 2004; 140: 518-527
34. Irvine EJ. Quality of life assessment in gastro-oesophageal reflux disease. Gut 2004; 53 (Suppl 4): iv35-iv39
35. Luckock MP, Morley S, White C et al. Responses of consecutive patients to reassurance after gastroscopy: results of a self administered questionnaire survey. BMJ 1997; 315: 572-575
36. 2-blocker therapy or prompt endoscopy in management of dyspepsia. Lancet 1994; 343: 811-816
37. French-Belgian Consensus Conference on Adult Gastro-oesophageal Reflux Disease. "Diagnosis and treatment": report of a meeting held in Paris, France, on 21-22 January 1999. The Jury of the Consensus Conference. Eur J Gastroenterol Hepatol 2000; 12: 129-137
38. Ware JE, Sherbourne CD. The MOS 36 items short form health survey (SF-36): conceptual framework and items selection. Med Care 1992; 30: 473-483
39. Dupuy HJ. The psychological general well-being index. In: Wenger NK, Mattson ME, Furberg CF (eds). Assessment of quality of life in trials of cardiovascular therapies. Darien, CT: Le Jacq Communications Inc, 1984: 170-183
40. EuroQoL Group. EuroQoL: a new facility for the measurement of health-related quality of life. Health Policy 1990; 16: 199-208
41. Svedlund J, Sjodin I, Dotevall G. GSRS: a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988; 33: 129-134
42. Locke GR, Talley NJ, Weaver AL et al. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc 1994; 69: 539-547
43. Velanovich FV, Vallance SR, Gusz JR et al. Quality of life scale for gastroesophageal reflux disease. J Am Coll Surg 1996; 183: 217-224
44. Young TL, Kirchdoerfer U, Osterhaus JT. A development and validation process for a disease-specific quality of life instrument. Drug Inf J 1996; 30: 185-193
45. Wiklund IK, Junghard O, Grace E et al. Quality of life in reflux and dyspepsia patients: psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl 1998; 583: 41-49
46. Eypasch E, Williams JI, Wood-Dauphinee S et al. Gastrointestinal quality of life index: development, validation and application of a new instrument. Br J Surg 1995; 82: 216-222